IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.895
AS - Asia 3.113
EU - Europa 2.848
SA - Sud America 517
AF - Africa 68
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.780
SG - Singapore 1.240
PL - Polonia 1.161
CN - Cina 946
BR - Brasile 430
UA - Ucraina 375
HK - Hong Kong 321
DE - Germania 286
IT - Italia 259
VN - Vietnam 233
FI - Finlandia 164
GB - Regno Unito 143
FR - Francia 132
RU - Federazione Russa 93
IN - India 87
TR - Turchia 75
IE - Irlanda 69
CA - Canada 54
BD - Bangladesh 50
AR - Argentina 41
NL - Olanda 39
MX - Messico 36
ID - Indonesia 32
SE - Svezia 29
ZA - Sudafrica 28
AU - Australia 26
JP - Giappone 24
CZ - Repubblica Ceca 23
AT - Austria 20
IQ - Iraq 19
ES - Italia 16
MA - Marocco 16
PK - Pakistan 14
EC - Ecuador 12
IL - Israele 12
BE - Belgio 10
JM - Giamaica 9
KE - Kenya 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CO - Colombia 8
LT - Lituania 8
SA - Arabia Saudita 7
PE - Perù 6
VE - Venezuela 6
CL - Cile 5
EU - Europa 5
IR - Iran 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
MY - Malesia 4
PY - Paraguay 4
UY - Uruguay 4
CH - Svizzera 3
CR - Costa Rica 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
NG - Nigeria 3
PA - Panama 3
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IS - Islanda 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
EG - Egitto 1
ET - Etiopia 1
KG - Kirghizistan 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
TC - Turks e Caicos 1
TW - Taiwan 1
Totale 11.473
Salva come PNG Salva come JPEG
Città #
Warsaw 1.158
Singapore 521
Ashburn 484
Woodbridge 415
Fairfield 383
Hong Kong 321
Jacksonville 276
San Jose 262
Houston 250
Beijing 214
Ann Arbor 194
Cambridge 178
Wilmington 171
Dallas 164
Chandler 161
Seattle 153
New York 145
The Dalles 141
Princeton 120
Los Angeles 99
Nanjing 97
Helsinki 95
Dearborn 83
Lauterbourg 76
Munich 65
Dublin 64
Ho Chi Minh City 63
Istanbul 61
Council Bluffs 60
Milan 49
Brescia 48
Buffalo 44
Dong Ket 42
Hanoi 42
San Francisco 40
São Paulo 39
Chicago 37
Moscow 34
Jinan 33
Shanghai 32
Nanchang 31
Boardman 30
Brooklyn 30
Lancaster 30
Shenyang 30
Des Moines 28
Santa Clara 27
London 25
Redondo Beach 24
San Diego 24
Jiaxing 22
Tianjin 22
Tokyo 22
Toronto 22
Changsha 21
Orem 20
Phoenix 20
Nuremberg 19
Chennai 18
Kunming 18
Hebei 17
Jakarta 17
Manchester 17
Hangzhou 16
Montreal 16
Rio de Janeiro 16
Turku 16
Verona 16
Zhengzhou 16
Atlanta 15
Johannesburg 15
Olomouc 15
Frankfurt am Main 14
Poplar 14
Stockholm 14
Florence 13
Groningen 13
Denver 12
Haikou 12
Lallio 12
Mumbai 12
Guangzhou 11
Amsterdam 10
Augusta 10
Brussels 10
Dhaka 9
Leawood 9
Mexico City 9
San Mateo 9
Baku 8
Belo Horizonte 8
Boston 8
Curitiba 8
Hải Dương 8
Nairobi 8
Ningbo 8
Querétaro 8
Salt Lake City 8
Taizhou 8
Brasília 7
Totale 7.869
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 360
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 315
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 311
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 282
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 281
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 274
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 270
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 248
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 228
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 217
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 213
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 212
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 206
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 204
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 193
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 183
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 174
Sialic acid as a target for the development of novel antiangiogenic strategies 173
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 167
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 157
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 155
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 155
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 152
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 151
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 148
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 147
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 147
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 141
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 135
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 127
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 127
Recent Strategic Advances in CFTR Drug Discovery: An Overview 127
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 124
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 124
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 122
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 121
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 117
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 116
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 115
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 114
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 113
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 112
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 110
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 108
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 107
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 103
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 103
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 102
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 100
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 98
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 97
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 97
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 97
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 96
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 94
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 94
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 93
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 92
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 92
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 90
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 90
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 88
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 88
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 86
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 84
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 82
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 80
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 80
Glycomics and angiogenesis: biological implications and therapeutical exploiting 79
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 77
UV-C EXPOSURE SUGGESTS A SARS-CoV-2 SPIKE PROTEIN ANTIVIRAL STRATEGY BASED ON REDUCING AGENTS 77
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 76
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 76
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 72
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 72
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 72
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 71
Exploring Alternative BAG3 Targeting Approaches for pediatric medulloblastoma: From small molecules lead optimization to Fragment-Based Drug Discovery 69
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers 69
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 66
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 64
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 60
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 59
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 59
implementation of an incremental docking method to study long sugar chains interactions with proteins 58
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 57
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 52
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 49
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 47
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 43
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming 17
Totale 11.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 0 0 0 0 79 115 75
2021/2022540 15 108 8 16 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/20251.798 20 10 7 188 94 109 117 54 139 246 524 290
2025/20263.681 389 521 355 570 399 288 591 134 228 206 0 0
Totale 11.637